- Report
- April 2023
- 115 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- April 2023
- 240 Pages
Global
From €3405EUR$3,500USD£2,917GBP
- Report
- June 2022
- 95 Pages
Global
From €3843EUR$3,950USD£3,292GBP
- Report
- January 2022
- 200 Pages
Global
From €7297EUR$7,500USD£6,251GBP
- Report
- August 2022
- 120 Pages
Global
From €4378EUR$4,500USD£3,751GBP
- Report
- November 2018
- 30 Pages
China
From €2141EUR$2,200USD£1,834GBP
- Report
- February 2018
- 680 Pages
Global
From €21406EUR$22,000USD£18,337GBP
- Report
- May 2022
- 120 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- April 2023
- 116 Pages
Global
From €4378EUR$4,500USD£3,751GBP
- Report
- August 2022
United States
From €1888EUR$1,940USD£1,617GBP
- Report
- August 2022
Global
From €1158EUR$1,190USD£992GBP
- Report
- February 2021
Global
From €2880EUR$2,960USD£2,467GBP
- Report
- August 2021
Europe
From €3328EUR$3,420USD£2,851GBP
- Report
- August 2021
Global
From €3882EUR$3,990USD£3,326GBP
- Report
- October 2022
- 81 Pages
Global
From €3401EUR$3,495USD£2,913GBP
- Report
- November 2020
- 36 Pages
Global
From €3887EUR$3,995USD£3,330GBP
- Drug Pipelines
- October 2020
- 811 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Report
- July 2023
- 133 Pages
China
From €1751EUR$1,800USD£1,500GBP
- Report
- July 2023
- 101 Pages
China
From €1751EUR$1,800USD£1,500GBP
- Report
- April 2023
- 109 Pages
Global
€3405EUR$3,500USD£2,917GBP
The Asthma Treatment market is composed of a variety of drugs used to treat asthma symptoms. These drugs are divided into two main categories: long-term control medications and quick-relief medications. Long-term control medications are taken daily to reduce inflammation and prevent asthma symptoms. Quick-relief medications are taken as needed to quickly relieve asthma symptoms. Common long-term control medications include inhaled corticosteroids, leukotriene modifiers, and long-acting beta-agonists. Common quick-relief medications include short-acting beta-agonists and anticholinergics.
The Asthma Treatment market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Novartis, Sanofi, and Teva Pharmaceuticals. Show Less Read more